Efficacy Of N-Acetylcysteine In Non- Acetaminophen Acute Liver Failure.
Keywords:
Acute liver failure, Acetylcysteine, EfficacyAbstract
Introduction: Acute liver failure (ALF) is a relatively rare, but severe, life-endangering medical emergency. To date, there is no established treatment for non-acetaminophen-induced acute liver failure (NAI-ALF) other than liver transplantation, and little is known about the use of N- acetylcysteine (NAC) in NAI-ALF.
Objective: To determine the efficacy of acetylcysteine in non-acetaminophen acute liver failure.
Study Design: Descriptive case series.
Setting: Department of Medicine, Mayo Hospital, Lahore.
Duration of Study: Study was carried out over a period of six months from 03-10-2021 to 03- 04-2022.
Material and Methods: Total 81 patients presented to the Department of Medicine, Mayo Hospital, Lahore, fulfilling the Inclusion criteria were selected. Informed consent was taken from each patient. All patients were given intravenous N-acetylcysteine (150mg/kg in 5% dextrose in 15 mins followed by 50mg/kg over 4 hours then 100mg/kg over 16 hours) for duration of 72 hours. All patients were followed by the researcher for 4 weeks and efficacy and analyzed in SPSS version 25.0 and presented as frequency and percentages.
Results: Total of 81 patients were included in the study, there were 66.7 %(n=54) were in age group of 20-40 years and 33.3% (n=27) were in age group of 41-70 years and mean age was calculated as 737.93±11.09 years. Gender distribution of the patients was done, it showed that 44.4 %(n=36) were male whereas 55.6% (n=45) were females. Percentage of efficacy of acetylcysteine in non- acetaminophen acute liver failure was 30.9%(n=25).
Conclusion: We concluded that in patients with non-acetaminophen-related acute liver failure, acetylcysteine significantly improves overall survival
Downloads
References
Hossain MM, Miah MAS, Hasan AMS, Tarafder BK, Alam MM, Siddique MAB. Biochemical alterations in acute liver failure and its relation with prognosis. Faridpur Med. Coll. J. 2018;13(1):17-9.
Teriaky A. The role of N-acetylcysteine in the treatment of non-acetaminophen acute liver failure. Saudi J Gastroenterol. 2017;23:131-2.
Devarbhavi H. Acute liver failure induced by antiinfectious drugs: causes and management. Current Hepatol Rep. 2017;16(4):276 -85.
Nabi T, Rafiq N, Arifa QA. A prospective study of N-acetylcysteine treatment in drug-induced fulminant hepatic failure. Int J Basic ClinPharmacol. 2019;8:1000-6.
Rodriguez TS, Miles M, McLeod M. A case of acute liver dysfunction due to trimethoprimsulfamethoxazole treated with n-acetylcysteine. J Can AssocGastroenterol. 2018;1(2):39.
Nabi T, Nabi S,Rafiq N, Shah A. Role of N-acetylcysteine treatment in non- acetaminophen-induced acute liver failure: a prospective study. Saudi J Gastroenterol. 2017;23(3):169–75.
Darweesh SK, Ibrahim MF, El-Tahawy MA. Effect of N-Acetylcysteine on mortality and liver transplantation rate in non-acetaminophen-inducedacute liver failure: a multicenter study. Clin Drug Investigation. 2017;37(5):473-82.
Jennifer M, Kevin F, Nicholas P. Evaluation of the efficacy of iv n-acetylcysteine for non- acetaminophen-induced acute liver failure.Critical Care Med.2020;48(1):219.
O’Grady JG, Schalm S W, Williams R. Acute liver failure: redefning the syndromes.Lancet. 1993;342:273–275
O’Grady JG, Williams R. Classifcation of acute liver failure. Lancet. 1993;342:743.
Lee WM. Acute liver failure in the United States. Semin Liver Dis. 2003;23:217–226
Lee WM, Squires RH, Nyberg SL, Doo E, Hoofnagle JH. Acute liver failure: Summary of a workshop. Hepatology. 2008;47:1401–1415.
ei G, Bergquist A, Broomé U, et al. Acute liver failure in Sweden: etiology and outcome.J Intern Med. 2007;262:393–401.
Larsen FS, Kirkegaard P, Rasmussen A, Hansen BA. The Danish liver transplantation program and patients with serious acetaminophen intoxication. Transplant Proc. 1995;27:3519–3520.
Escorsell A, Mas A, de la Mata M. Acute liver failure in Spain: analysis of 267 cases. Liver Transpl. 2007;13:1389–1395.
Leifeld L, Merk P, Schmitz V, et al. Course and therapy of acute liver failure. Eur J Med Res. 2008;13:87–91.
Hadem J, Stiefel P, Bahr MJ, et al. Prognostic implications of lactate, bilirubin, and etiology in German patients with acute liver failure. Clin Gastroenterol Hepatol. 2008;6:339–345.
Canbay A, Jochum C, Bechmann LP, et al. Acute liver failure in a metropolitan area in Germany: a retrospective study (2002-2008) Z Gastroenterol. 2009;47:807–813.
Schimanski CC, Burg J, Möhler M, et al. Phenprocoumon-induced liver disease ranges from mild acute hepatitis to (sub-) acute liver failure. J Hepatol. 2004;41:67–74.
Schmidt LE, Dalhoff K. Concomitant overdosing of other drugs in patients with paracetamol poisoning. Br J Clin Pharmacol. 2002;53:535–541.
Hawton K, Bergen H, Simkin S, Dodd S, Pocock P, Bernal W, Gunnell D, Kapur N. Long term effect of reduced pack sizes of paracetamol on poisoning deaths and liver transplant activity in England and Wales: interrupted time series analyses. BMJ. 2013;346:f403.
Schwalfenberg GK. N-Acetylcysteine: A Review of Clinical Usefulness (an Old Drug with New Tricks). Journal of Nutrition and Metabolism. 2021 Jun 10;2021..
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
